Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece

References

• World Health OrganizationGlobal atlas on cardiovascular disease prevention and control2011 Available from: http://www.who.int/cardiovascular_diseases/en/Accessed April 23, 2012
   Google Scholar
• MackayJMensahGAtlas of Heart Disease and StrokeGeneva, SwitzerlandWorld Health Organization2004
   Google Scholar
• Hellenic Statistical AuthorityConcise Statistical Yearbook2009 Available from: http://www.statistics.grAccessed April 23, 2012Greek
   Google Scholar
• PitsavosCMiliasGAPanagiotakosDBXenakiDPanagopoulosGStefanadisCPrevalence of self-reported hypertension and its relation to dietary habits in adults; a nutrition and health survey in GreeceBMC Public Health2006620616904009
   PubMed Web of Science ®Google Scholar
• EfstratopoulosADVoyakiSMBaltasAAPrevalence awareness treatment and control of hypertension in Hellas Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national studyAm J Hypertens2006191536016461191
   PubMed Web of Science ®Google Scholar
• AthyrosVGGanotakisESBathianakiMAwareness treatment and control of the metabolic syndrome and its components: a multicentre Greek studyHellenic J Cardiol200546638038616422124
   PubMedGoogle Scholar
• SarafidisPALasaridisAGousopoulosSPrevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa studyJ Hum Hypertens200418962362915029221
   PubMed Web of Science ®Google Scholar
• PsaltopoulouTOrfanosPNaskaALenasDTrichopoulosDTrichopoulouAPrevalence awareness treatment and control of hypertension in a general population sample of 26913 adults in the Greek EPIC studyInt J Epidemiol20043361345135215218014
   PubMed Web of Science ®Google Scholar
• PanagiotakosDBPitsavosCChrysohoouCSkoumasJStefanadisCStatus and management of blood lipids in Greek adults and their relation to socio-demographic lifestyle and dietary factors: the ATTICA Study. Blood lipids distribution in GreeceAtherosclerosis2004173235336115064113
   PubMed Web of Science ®Google Scholar
• GikasASotiropoulosAPanagiotakosDPeppasTSklirosEPappasSPrevalence and associated risk factors of self-reported diabetes mellitus in a sample of adult urban population in Greece: MEDICAL Exit Poll Research in Salamis (Medical Express 2002)BMC Public Health20044215028111
   PubMed Web of Science ®Google Scholar
• PanagiotakosDBPitsavosCHChrysohoouCStatus and management of hypertension in Greece: role of the adoption of a Mediterranean diet: the ATTICA studyJ Hypertens20032181483148912872041
   PubMed Web of Science ®Google Scholar
• ManiadakisNKourlabaGFragoulakisVSelf-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone surveyBMC Cardiovasc Disord2011111621492471
   PubMed Web of Science ®Google Scholar
• LakattaEGAge-associated cardiovascular changes in health: impact on cardiovascular disease in older personsHeart Fail Rev200271294911790921
   PubMedGoogle Scholar
• Lloyd-JonesDAdamsRJBrownTMAmerican Heart AssociationExecutive summary: heart disease and stroke statisticsCirculation2010121794895420177011
   PubMed Web of Science ®Google Scholar
• LealJLuengo-FernandezRGrayAPetersenSRaynerMEconomic burden of cardiovascular diseases in the enlarged European UnionEur Heart J200627131610161916495286
   PubMed Web of Science ®Google Scholar
• SuhrckeMUrbanDAre cardiovascular diseases bad for economic growth?Health Econ201019121478149619998332
   PubMed Web of Science ®Google Scholar
• Guideline Summary [webpage on the Internet]Rockville, MDAgency for Healthcare Reseach and Quality Available from: http://www.guideline.gov/content.aspx?id=33603&search=cardiovascular#Section420Accessed April 23, 2012
   Google Scholar
• AraujoDVBahiaLSouzaCPRPavãoALBCost-effectiveness and budget impact analysis of rosuvastatin and atorvastatin for LDL-cholesterol and cardiovascular events lowering within the SUS* scenarioInt J Atheroscler200723189194
   Google Scholar
• AsztalosBFLe MaulfFDallalGEComparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteinsAm J Cardiol200799568168517317371
   PubMed Web of Science ®Google Scholar
• BullanoMFKamatSWertzDAEffectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care settingAm J Health Syst Pharm200764327628417244877
   PubMed Web of Science ®Google Scholar
• JonesPHHunninghakeDBFerdinandKCEffects of rosuvastatin versus atorvastatin simvastatin and pravastatin on non-high-density lipoprotein cholesterol apolipoproteins and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trialClin Ther20042691388139915531001
   PubMed Web of Science ®Google Scholar
• MotskoSPRussmannSMingEESinghVPVendiolaRMJonesJKEffectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events – a cohort study in 395,039 patients from clinical practicePharmacoepidemiol Drug Saf200918121214122219780020
   PubMed Web of Science ®Google Scholar
• ConroyRMPyoralaKFitzgeraldAPEstimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE projectEur Heart J20032411987100312788299
   PubMed Web of Science ®Google Scholar
• PanagiotakosDBFitzgeraldAPPitsavosCPipilisAGrahamIStefanadisCStatistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project)Hellenic J Cardiol2007482556317489342
   PubMedGoogle Scholar
• Framingham Heart StudyHard coronary heart disease (10-year risk) Available from: http://www.framinghamheartstudy.org/risk/hrdcoronary.htmlAccessed April 23, 2012
   Google Scholar
• ManiadakisNKaitelidouDSiskouOEconomic evaluation of treatment strategies for patients suffering acute myocardial infarction in GreeceHellenic J Cardiol200546321222115981557
   PubMedGoogle Scholar
• LawMRWaldNJRudnickaARQuantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ20033267404142312829554
   PubMed Web of Science ®Google Scholar
• JonesPKafonekSLauroraIHunninghakeDComparative dose efficacy study of atorvastatin versus simvastatin pravastatin lovastatin and fluvastatin in patients with hypercholesterolemia (the CURVES study)Am J Cardiol19988155825879514454
   PubMed Web of Science ®Google Scholar
• The Ministry for Health and Social SolidarityPrice bulletin Available from: http://www.yyka.gov.gr/articles/times-farmakwn/deltia-timwnMinistry of Health2012Accessed April 23, 2012Greek
   Google Scholar
• BriggsAProbabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertaintyValue Health2005811215841888
   PubMed Web of Science ®Google Scholar
• BennerJSSmithTWKlingmanDCost-effectiveness of rosuvastatin compared with other statins from a managed care perspectiveValue Health20058661862816283862
   PubMed Web of Science ®Google Scholar
• PalmerSJBradyAJRatcliffeAEThe cost-effectiveness of a new statin (rosuvastatin) in the UK NHSInt J Clin Pract200357979280014686571
   PubMed Web of Science ®Google Scholar
• OhsfeldtRLGandhiSKFoxKMStacyTAMcKenneyJMEffectiveness and cost-effectiveness of rosuvastatin atorvastatin and simvastatin among high-risk patients in usual clinical practiceAm J Manag Care200612Suppl 15S412S42317112329
   PubMed Web of Science ®Google Scholar
• PintoCGCarragetaMOMiguelLSCost-effectiveness of rosuvastatin in the prevention of ischemic heart disease in PortugalValue Health200811215415918380628
   PubMed Web of Science ®Google Scholar
• Costa-ScharplatzMRamanathanKFrialTBeamerBGandhiSCost-effectiveness analysis of rosuvastatin versus atorvastatin simvastatin and pravastatin from a Canadian health system perspectiveClin Ther20083071345135718691996
   PubMed Web of Science ®Google Scholar
• OhsfeldtRLGandhiSKSmolenLJCost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trialJ Med Econ201013342843720662625
   PubMedGoogle Scholar
• RosensonRSRosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemiaExpert Rev Cardiovasc Ther20031449550515030249
   PubMedGoogle Scholar